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Abstract 
Purpose: The Patient Assessment of Chronic Illness Care (PACIC) was created to assess 
whether provided care is congruent with the Chronic Care Model, according to patients. We 
aimed to identify all studies using the PACIC in diabetic patients to explore i) how overall PACIC 
scores varied across studies and ii) whether scores varied according to healthcare delivery, 
patient, and instrument characteristics. 
Data sources: Medline, Embase, Cinahl, Psychinfo, and Pubmed Central, from 2005 to 2016. 
Study selection: Studies of any design using the PACIC in diabetic patients.  
Data extraction and synthesis: We extracted data on healthcare delivery, patient, and 
instrument characteristics, and overall PACIC score and standard deviation. We performed 
random-effects meta-analyses and meta-regressions. 
Results: We identified 34 studies including 25,942 patients from 13 countries, mostly in North 
America and Europe, using different versions of the PACIC in 11 languages. The overall PACIC 
score fluctuated between 1.7 and 4.2, with a pooled score of 3.0 (95% confidence interval 2.8 
to 3.2, 95% predictive interval 1.9 to 4.2), with very high heterogeneity (I2 = 99%). The PACIC 
variance was not explained by healthcare delivery or patient characteristics, but by the 
number of points on the response scale (5 versus 11) and the continent (Asia versus others). 
Conclusion: The PACIC is a widely used instrument, but the direct comparison of PACIC scores 
between studies should be performed with caution as studies may employ different versions 
and the influence of cultural norms and language on the PACIC score remains unknown. 
Key words 
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Introduction 
The Chronic Care Model is a widely used evidence-based framework developed to guide 
healthcare systems for the delivery of high-quality care for patients with chronic diseases [1]. 
The Patient Assessment of Chronic Illness Care (PACIC) instrument assesses whether care is 
congruent with the Chronic Care Model, according to patients [2]. In a context of increasing 
attention towards program evaluation and the consideration of patient reported outcomes 
and experiences measures (PROMS [3, 4] and PREMS [5]), the PACIC is increasingly used in 
clinical studies and evaluations of healthcare services and has been described as “the most 
appropriate instrument to measure the experience of people receiving integrated chronic 
care” in a review of 31 instruments published in 2009 [6]. 
Up to now, studies using the PACIC have shown mixed results regarding the association of the 
overall score and healthcare delivery and patient characteristics. Some studies have shown 
that PACIC scores improved after implementation of interventions aimed to improve chronic 
care delivery [7, 8] while other studies reported no improvement or lower PACIC scores [9, 
10]. Studies have also reported opposing findings regarding the impact of socio-demographic 
characteristics, such as gender and age [2, 11, 12].  
To our knowledge, the systematic exploration of the PACIC use and scores across studies has 
not yet been performed. In that context, the aims of this study were to systematically identify 
all studies using the PACIC instrument to explore the variation of overall PACIC scores across 
studies, and according to: i) healthcare delivery characteristics, ii) patient characteristics, and 
iii) instrument characteristics. We hypothesized that the variance of the overall PACIC scores 
would be mainly explained by the type of care patients received (i.e. patients receiving 
integrated care would have higher PACIC scores compared to patients receiving usual care). 
We chose to focus on PACIC scores in diabetic populations as the instrument has been 
validated and widely used in this population [13] . 
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Methods 
Data sources 
We performed a systematic search of four indexed databases (Medline, Embase, PsychInfo, 
Cinahl) and Pubmed Central, without language restrictions, between January 2005, year of the 
first PACIC validation study, and October 2016. We used MeSH and free text words for the 
two main concepts, “PACIC” and “diabetes” (Supplementary material 1).  
Study selection 
Studies including patients diagnosed with type 1 or type 2 diabetes, receiving any type of care 
in any setting, and considering the PACIC instrument (the 11-, 20-, or 26-item version [2, 13, 
14]), were eligible for inclusion. Since we focused our interest on mean PACIC scores and their 
variations, any type of observational study (e.g. cross-sectional (XS), cohort) or interventional 
study (e.g. randomized-controlled trial (RCT), controlled before-after study (CBA), before-after 
study (BA)) were considered. We excluded studies including patients with multiple chronic 
diseases if they did not present subgroup results for patients with diabetes. Studies were also 
excluded if only one item or dimension of the PACIC was measured or if a modified version of 
the PACIC was used. 
After a first title and abstract screening, the full text of primary studies were evaluated by two 
authors (CA and IPB), working independently and in duplicate, to determine whether they met 
the eligibility criteria. 
Primary outcome and effect modifiers 
Our primary outcome was the overall PACIC score. The PACIC is a 20-item instrument 
measuring the extent to which patients report having received specific actions and care that 
are congruent with various aspects of the Chronic Care Model [2]. The original questionnaire 
was developed in English and has been translated and tested in many languages. Each item is 
scored on a 5-point scale, ranging from 1 to 5, and the overall PACIC is scored by averaging 
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scores across all 20 items. The anchors of the 5-point scale are ‘never / always’ or ‘almost 
never / almost always’. Two other versions have been validated: a 26-item version called 
PACIC-5As [13] and an 11-item short version [14], with an 11-point scale ranging from ‘none 
(0)’ to ‘always (100)’.  
We pre-defined the following effect modifiers: a) healthcare delivery characteristics: setting 
(community, primary care practices, hospital or diabetes clinics, or mixed), usual care or 
integrated care (e.g. managed care, disease management program), healthcare professionals 
involved in patient care (general practitioners, others professionals (e.g. specialists, nurses, 
dietitians); b) patient characteristics: age (mean age, dichotomized at the study level as under 
or above 65), gender (percentage of men, dichotomized at the study level as under or above 
50%), and type of diabetes (dichotomized at the study level as type 2 or any type); c) study 
characteristics: country (categorized into continents and dichotomized into high-income 
economy versus others [15]), study quality (strong, moderate, or weak) [16, 17]; and d) PACIC 
characteristics: number of items, language, anchors of the response scale (‘never’ versus 
‘almost never’), and response scale (5-point versus 11-point). 
Data extraction 
We extracted, independently and in duplicate, the overall PACIC score and standard deviation 
(SD) as well as the above characteristics.  We contacted authors of 20 primary studies to obtain 
missing data; 14 replied and ten sent additional data. Missing SDs were replaced by the 
median SD of the other studies.  
Study quality 
We assessed the overall quality of the studies as strong, moderate, or weak, based on the 
assessment of the risk of bias measured with a modified version of the Effective Public Health 
Practice Project quality assessment tool [16, 17] ( Supplementary material 2). The quality of 
the studies was assessed globally, even if we only considered baseline data in this review. 
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Data management and synthesis  
In studies with more than one study group, we considered the data separately if groups 
received different types of care (usual care versus integrated care) or if the settings were 
different, and combined the data if groups received the same type of care in the same setting, 
using the formula presented in the section 7.7.3.8 of the Cochrane Handbook for Systematic 
Reviews of Interventions [18]. For studies with before and after data (RCTs, CBAs, BAs), only 
baseline data were considered. If authors did not use the 5-point response scale for the PACIC 
score, we cross-multiplied the score to match the 5-point scale score. As most studies using 
the 26-item version provided the overall PACIC score (calculated on the same 20 items of the 
original instrument), we combined the studies using either questionnaire in the same analyses 
and investigated the impact of the study presenting the 5A summary score (calculated on 15 
of the original items) [19] in sensitivity analyses. We analyzed separately the overall score 
calculated with the 11-item version. 
First, random-effects meta-analyses were performed to obtain the pooled mean overall PACIC 
score, the 95% confidence interval (CI), the 95% prediction interval (PI) [20], and the I2, 
measuring the level of heterogeneity between studies. We performed sensitivity analyses 
excluding studies of weak quality. Second, we conducted subgroup analyses and univariate 
meta-regressions to explore heterogeneity and identify healthcare delivery, patient, and 
PACIC characteristics possibly associated with overall PACIC scores and explaining variance 
between studies (adjusted R2 in univariate meta-regression). Third, we conducted multivariate 
meta-regressions, building a model with the forward selection approach using the adjusted R2 
as criterion for variable selection and retention.  
Results 
Results of our search strategy are presented in Figure 1; we included 32 studies [8-10, 12, 13, 
19, 21-46] and 34 studies in the quantitative and qualitative synthesis of this review, 
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respectively (two studies [47, 48] did not report overall PACIC scores). In addition, we 
identified three ongoing studies [49-51] and two studies without published results [52-54], 
presented in Supplementary material 4.  
Qualitative synthesis 
Details of the included studies are presented in Supplementary material 3.  
Study characteristics 
Most studies were XS studies (n=22); six studies were RCTs, four studies were BAs, and two 
studies were CBAs.  The included studies were conducted in 13 different countries, mostly in 
North America (n=16) and in Europe (n=10); five studies [26-28, 32, 47] were conducted in 
low- and middle-income economies. 
Healthcare delivery characteristics  
The healthcare setting was primary care practices (n=18), hospital outpatient clinics (n=3), the 
community (n=2), diabetes clinics (n=1), and a mix of settings (n=9). General practitioners 
were the main providers of care in 11 studies, while GPs and/or other healthcare professionals 
provided care in 12 studies, the type of providers being unclear in the remaining studies. At 
baseline, all patients were receiving usual care in 20 studies and integrated care in six studies 
[12, 33, 36, 37, 44, 47]; in seven studies [9, 21, 27, 29-31, 34], some patients were receiving 
usual while the others were receiving integrated care. 
Patient characteristics 
Studies included between 40 and 3761 patients (576.5 on average and 25,942 in total), of a 
mean age varying between 54 and 75.8 years (mean age < 65 in 40% of study groups). The 
percentage of male patients ranged between 21% and 98% (percentage men < 50% in 48% of 
study groups), and patients were diagnosed with type 2 diabetes in the majority of studies 
(n=27).   
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PACIC characteristics 
Studies used mainly the 20-item version (n=24); five studies [13, 19, 29, 33, 36] used the 26-
item version, three studies [14, 44, 45] used the 11-item version, and two studies did not 
specify the version [30, 48]. While the majority of studies utilized the 5-point response scale, 
ranging from 1 to 5 (n=29), the three studies using the 11-item version and two other studies 
[35, 40] utilized an 11-point response scale, ranging from 0 to 100. Among studies reporting 
the anchors, ten studies employed ‘never / always’ whereas 11 studies employed ‘almost 
never / almost always’.  
The questionnaire was provided to patients in 11 different languages: in English in 11 studies, 
in German [8, 29, 34], Dutch [10, 33, 37], and Spanish [12, 35, 40] in three studies each, in 
Cantonese in two studies [35, 40], and in Danish [22], French [25], Italian [45], Mandarin [21], 
Thai [27], and Turkish [32] in one study each.  
Study quality 
Overall, the quality of studies was rated as moderate for three quarters of the studies (n=24); 
eight studies were rated as weak, one study as strong, and one study as unknown (Table 1).  
Quantitative synthesis 
Intervention and control groups of RCTs and CBAs were combined at baseline in all studies 
except one [30], while intervention and control groups of seven XS studies were considered 
separately, resulting in 43 study groups for the quantitative analyses. 
Variation in PACIC scores and meta-analysis 
Mean overall PACIC scores fluctuated between 1.7 (SD 0.4) and 4.2 (SD 5.2); eight study groups 
(19%) had an overall PACIC score lower than 2.5, whereas five study groups (12%) had an 
overall PACIC score higher than 3.5.  
The random-effects meta-analysis including the 40 study groups using the 20- or 26-item 
version showed a pooled overall PACIC score of 3.0, at the center point of the scale (95% CI 
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2.8 to 3.2, 95% PI 1.9 to 4.2) (Figure 2). The pooled overall PACIC score for the three studies 
using the 11-item version was 2.8 (95% CI 1.8 to 3.9, 95% PI -11.0 to 16.6) (Figure 2). 
Heterogeneity was very high in both groups (I2=99.5%). In sensitivity analyses, removing 
studies of weak quality and the study presenting the 5A summary score did not alter the 
results.  
Subgroup analyses and meta-regressions 
In the subgroup analyses among studies using the 20- or 26-item version, differences in scores 
between subgroups varied between 0 and 1 (median: 0.3); heterogeneity remained very high 
in all subgroups (Table 2). 
In univariate meta-regressions (Table 2), whereas the response scale (5- versus 11-point) and 
the continent (Asia versus other continents) were significantly associated with higher PACIC 
scores, having a GP as main provider (versus a GP and/or other healthcare professionals) was 
significantly associated with lower PACIC scores. The final multivariate model included the 
response scale and the continent, explaining 33% of the variance and significantly predicting 
higher PACIC scores. 
Removing the two studies using an 11-point response scale from the analyses altered the 
results of univariate meta-regressions: gender, type of anchors, continent, and age, explaining 
20%, 18%, 16% and 11% of the variance, respectively, were significantly associated with higher 
PACIC scores. However, none of these variables remained significant when combined in a 
multivariate model.  
Discussion 
Our systematic review of the literature on the use of the PACIC instrument in patients with 
diabetes identified 34 studies using the PACIC, in 11 different languages in 13 countries, 
predominantly in North America and Western Europe. Studies were mainly conducted in 
primary care practices; two thirds of patients were receiving usual care, while one third was 
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receiving integrated care. The majority of studies employed the 20- or 26-item instrument and 
a 5-point response scale; while half adopted the ‘never / always’ anchors, the other half 
adopted the ‘almost never / almost always’ anchors. Mean overall PACIC scores fluctuated 
between 1.7 and 4.2, with a pooled overall score of 3.0, at the center of the scale. The 
heterogeneity of the scores was very high and remained high in all subgroup analyses.  
Our main hypothesis, that patients receiving integrated care would have significantly higher 
scores, was not verified in the analyses. The two variables significantly predicting higher PACIC 
scores were an instrument characteristic, i.e. using a 5-point response scale (versus an 11-
point scale), and a study characteristic, i.e. taking place in Asia (versus in other continents); 
the choice of anchors (‘never’ versus ‘almost never’) also became a significant predictor when 
we excluded the two studies using the 11-point scale from the analyses. Having these two 
instrument characteristics as significant predictors is not surprising as the number of points 
on a scale and the type of anchors are essential elements in response style, where 
acquiescence (agreeing with items), extremity (favoring the extreme point) and moderation 
(favoring the midpoint) affect how individuals answer a Likert scale [55]. Consequently, 
interpreting the combined results of studies using different number of points on the response 
scale and different anchors requires caution as response styles might explain observed 
differences. In addition, previous studies have shown that response styles vary substantially 
between countries [55-57].  
These issues add to the complexity of comparative research, where similarities and 
differences between population groups are investigated with self-reported instruments, 
requiring not only that the measured constructs have the same factorial structure (i.e. 
configural invariance), but also that the comparison of the means between groups are 
meaningful and defensible (i.e. strong and strict factorial invariance) [58]. The required strong 
factorial invariance, also called scalar invariance, is especially an issue in cross-national and 
cross-cultural comparisons as cultural norms and language are likely to influence rating 
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tendency and yield different scores that do not reflect difference in care but rather differences 
in the way populations answer questions. Thus, the finding that patients in Asia tended to 
report higher PACIC scores on average compared to patients in other continents, could be due 
to differences in culture or language.  
We found PACIC score differences between subgroups ranging between 0 and 1. If we look at 
the observed score differences in terms of effect size using Cohen’s effect size classification 
(0.2=small, 0.5=medium, 0.8=large) [59], the impact of the number of points on the scale (5-
point versus 11-point) would represent a large effect, whereas the impact of the continent 
(Asia versus other continents) would represent a medium effect. What such a score difference 
means, and whether these differences are meaningful to patients, remain unclear, however, 
requiring thus caution when interpreting PACIC results. In fact, up to now, no minimal 
important difference (MID), which provides a “measure of the smallest change in the patient-
reported outcome of interest that patients perceive as important, either beneficial or harmful, 
and that would lead the patient or clinician to consider a change in management” [60], has 
been defined for the PACIC instrument. Longitudinal studies have reported statistically 
significant changes in PACIC scores after the implementation of the Chronic Care Model (e.g. 
a mean change of 0.2 in a RCT [8] and mean change of 0.3 in a BA [26]), but whether these 
changes were clinically significant remains undetermined. To derive a MID for the PACIC, 
anchor-based and distribution-based approaches could be combined as suggested in the 
literature [61, 62], using meaningful patient experiences and outcomes measures as anchors. 
In addition, the interpretability of the PACIC, defined as the degree to which one can assign 
qualitative meaning to an instrument’s quantitative scores or change in scores [61], and its 
sensitivity to detect change, also need to be further thoroughly investigated. 
The main strength of the study is that, to our knowledge, this systematic review is the first to 
have examined the use of the PACIC instrument worldwide and the variation of PACIC scores 
across studies, pooling evidence from 13 countries. However, the following two main 
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limitations need to be considered when interpreting the results. First, the PACIC was neither 
created nor tested to make cross-national comparisons. This means that observed differences 
in scores between studies and countries may be due to cultural factors and nation-specific 
rating tendencies rather than to differences in chronic care received. Second, it was only 
possible to systematically extract a few characteristics that could then be used in the subgroup 
analyses. Other potential effect modifiers, such as health literacy [36] and number and type 
of comorbidities [2], which might explain differences and between study variance, were not 
available.  
Even if the PACIC is a widely used instrument to assess care according to patients, the direct 
comparison of PACIC scores between studies should be performed with caution because 
studies may employ different versions of the instrument and it remains unknown how cultural 
factors affect its overall score. We encourage future research to investigate the 
appropriateness of using the PACIC instrument to compare chronic care across groups and 
countries, and to determine the minimal important difference to help interpreting the clinical 
significance of observed differences.   
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Table 2. Subgroup analyses: pooled overall PACIC scores, heterogeneity, and explained 
variance, according to healthcare delivery, patient and PACIC characteristics. 
Characteristics N1 Pooled overall PACIC  
scores (95% CI) 
Heterogeneity Explained 
variance2  
Healthcare delivery characteristics     
Integrated care 
Usual care 
13 
27 
3.2 (2.9 to 3.6) 
2.9 (2.8 to 3.1) 
99.7% 
98.9% 
4.7% 
GP and/or other healthcare professionals 
GP only 
12 
15 
3.2 (2.8 to 3.6) 
2.8 (2.6 to 2.9) 
99.8% 
98.3% 
13.3% 
PCP and/or other settings 
Primary care practices 
18 
22 
3.2 (2.9 to 3.5) 
2.9 (2.8 to 3.0) 
98.6% 
99.6% 
8.9% 
Low- and middle-income economies  
High-income economies 
7 
33 
3.2 (3.1 to 3.4) 
3.0 (2.8 to 3.2) 
94.2% 
99.6% 
0% 
Asia 
Other continents 
9 
31 
3. 4 (3.1 to 3.7) 
2.9 (2.8 to 3.1) 
99.3% 
98.7% 
15.9% 
Patient characteristics     
Patients’ mean age > 65 
Patients’ mean age < 65 
21 
16 
3.1 (2.8 to 3.4) 
2.9 (2.8 to 3.1) 
99.6% 
98.5% 
1.9% 
% of men > 50% 
% of men < 50% 
21 
19 
3.2 (2.9 to 3.4) 
2.9 (2.8 to 3.0) 
99.4% 
98.3% 
6.6% 
Type 2 diabetes only 
Type 1 and/or type 2 diabetes 
33 
4 
3.1 (2.9 to 3.3) 
2.7 (2.3 to 3.1) 
99.6% 
97.2% 
4.0% 
PACIC characteristics     
English 
German 
Other 
9 
7 
14 
3.0 (2.8 to 3.3) 
3.0 (2.7 to 3.3) 
3.1 (2.7 to 3.5) 
99.0% 
98.9% 
99.7% 
-6.4% 
‘Almost never’ to ‘almost always’ anchors 
‘Never’ to ‘always’ anchors 
16 
12 
3.2 (2.9 to 3.5) 
2.9 (2.7 to 3.1)  
99.6% 
98.6% 
6.7% 
5-point scale 
11-point scale 
38 
2 
3.1 (2.9 to 3.3) 
2.1 (1.8 to 2.3) 
99.5% 
84.1% 
20.0% 
GP: general practitioner, PCP: primary care practice, CI: confidence interval 1number of observations in each 
subgroup 2Adjusted R2 in univariate meta-regression 
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Figure 1 PRISMA flow diagram 
See eps file Fig 1 
Figure 2 Forest-plot of overall PACIC score by study group, according to PACIC version 
See eps file Fig 2 
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Supplementary materials 
Supplementary material 1. Search strategy 
Supplementary material 2. Risk of bias tool 
Supplementary material 3. Characteristics of studies using the PACIC instrument among 
patients with diabetes 
Supplementary material 4. Characteristics of ongoing studies or studies without published 
results using the PACIC instrument among patients with diabetes. 
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The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis 
Supplementary material 1. Search Strategy 
 
Ovid MEDLINE (ran Oct 17, 2016) 
1 exp Diabetes Mellitus/ (360749) 
2 diabet*.mp. (555993) 
3 1 or 2 (557604) 
4 PACIC*.mp. (101) 
5 “Patient Assessment of Chronic Illness Care”.mp. (91) 
6 4 or 5 (121) 
7 3 and 6 (48) 
 
Ovid Embase (ran Oct 13, 2016) 
1 exp diabetes mellitus/ (786658) 
2 diabet*.tw. (707089) 
3 1 or 2 (871856) 
4 PACIC.tw (129) 
5 Patient Assessment of Chronic Illness Care.tw (102) 
6 4 or 5 (154) 
7 3 and 6 (67) 
 
Ovid PsycINFO (ran Oct 13, 2016) 
1 exp diabetes mellitus/ (6780) 
2 diabet*.tw. (25097) 
3 1 or 2 (25528) 
4 PACIC.tw (28) 
5 Patient Assessment of Chronic Illness Care.tw (30) 
6 4 or 5 (35) 
7 3 and 6 (16) 
 
CINAHL (ran Oct 13, 2016) 
(MH “diabetes mellitus” OR TX diabet*) AND (TX PACIC OR Patient Assessment of Chronic 
Illness Care) (23) 
 
PMC (PubMed Central) (ran Oct 17, 2016) 
(diabetes* or diabetic* or diabetol*) AND (pacic OR "patient assessment of chronic illness 
care") (265) 
 
The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis - p1 
Supplementary table 2. Risk of bias tool (adapted from the EPHPP) 
 
Study ID (Author Year): ________________________ Rater initials: _______ Date: ___________ 
Notes: 
 
 
 
 
 
A) SELECTION BIAS  
(A1) Are the individuals selected to participate in the study likely to be representative of the target 
population?  
1 Very likely  
2 Somewhat likely  
3 Not likely  
4 Can’t tell  
Patients would be representative if they comprised the entire source population, an unselected 
sample of consecutive patients, or a random sample (score very likely). They may not be 
representative if they are referred from a source (e.g. clinic) in a systematic manner (score somewhat 
likely) or self-referred (score not likely). 
 (A2) What percentage of selected individuals agreed to participate / replied to survey?  
1 80 - 100% agreement  (60-100% response rate if survey) 
2 60 – 79% agreement  (40-60% response rate if survey) 
3 less than 60% agreement (<40% response rate if survey) 
4 Not applicable  
5 Can’t tell  
For interventional studies: Refers to the % of subjects that agreed to participate before they were 
assigned to a group  
For survey-based studies: Refers to the % of subjects that returned the questionnaire/survey in cross-
sectional studies (not the % of subjects without missing data) 
 
RATE THIS SECTION  STRONG  MODERATE  WEAK  
Strong: Selected individuals are very likely to be representative of 
the target population (Q1 is 1) and > 80% participation / 60-100% 
response rate  (Q2 is 1). 
Moderate: Selected individuals are at least somewhat likely to be 
representative of the target population (Q1 is 1 or 2); and 60 - 79% 
participation / 40-60% response rate (Q2 is 2). ‘Moderate’ may also 
be assigned if Q1 is 1 or 2 and Q2 is 5 (can’t tell). 
Weak: Selected individuals are not likely to be representative of 
the target population (Q1 is 3); or there is <60% participation / 
<40% response rate (Q2 is 3) or selection is not described (Q1 is 4); 
and level of participation is not described (Q2 is 5). 
1 2 3 
The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis - p2 
B) STUDY DESIGN  
(B1) Indicate the study design  
1 Randomized controlled trial (RCT) 2 Controlled clinical trial (CCT) 
3 Cohort analytic (two group pre + post)  4 Case-control  
5 Cohort (one group pre + post (before and after)) (BA) 6 Interrupted time series (ITS) 
7 Cross-sectional study (XS) 8 Other specify ________________________  
9 Can’t tell 
(B2) Were there two study groups?  
No  Yes  
(B3) Was the study described as randomized?  
No  Yes  Not applicable 
(B4) If Yes, was the method of randomization described? (See dictionary)  
No  Yes   Not applicable 
(B5) If Yes, was the method appropriate? (See dictionary)  
No  Yes  Not applicable 
 
RATE THIS SECTION  STRONG  MODERATE  WEAK  
Strong: RCTs, CCT; Moderate: cohort study, case control study, 
before-after, ITS; Weak: cross-sectional, other design 
1 2 3 
 
C) CONFOUNDERS  
(C1) Were there important differences between groups prior to the intervention?  
1 Yes  3 Can’t tell  
2 No  4 Not applicable (for cross-sectional or before-after studies with one study group only) 
The following are examples of confounders:  
1 Race 2 Sex  
3 Marital status/family  4 Age  
5 SES (income or class)  6 Education  
7 Health status  8 Pre-intervention score on outcome measure  
(C2) If yes, indicate the percentage of relevant confounders that were controlled (either in the 
design (e.g. stratification, matching) or analysis)?  
1 80 – 100% (most)  
2 60 – 79% (some)  
3 Less than 60% (few or none)  
4 Can’t Tell  
5 Not applicable (for cross-sectional or before-after studies with one study group only) 
 
RATE THIS SECTION  STRONG  MODERATE  WEAK  N/A 
Strong: will be assigned to those articles that controlled for 
at least 80% of relevant confounders (Q1 is 2); or (Q2 is 1). 
Moderate: will be given to those studies that controlled for 
60 – 79% of relevant confounders (Q1 is 1) and (Q2 is 2). 
Weak: will be assigned when < 60% of relevant confounders 
were controlled (Q1 is 1) and (Q2 is 3) or control of 
confounders was not described (Q1 is 3) and (Q2 is 4). 
1 2 3 4 
The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis - p3 
D) BLINDING  
(D1) Was the outcome assessor aware of the intervention or exposure status of participants?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (for cross-sectional or before-after studies with one study group only) 
(D2) Were the study participants aware of the research question?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (for cross-sectional or before-after studies with one study group only) 
 
RATE THIS SECTION  STRONG  MODERA  WEAK  N/A 
Strong: Outcome assessor is not aware of the intervention 
status of participants (Q1 is 2); and study participants are not 
aware of the research question (Q2 is 2). 
Moderate: Outcome assessor is not aware of the intervention 
status of participants (Q1 is 2); or study participants are not 
aware of the research question (Q2 is 2); or blinding is not 
described (Q1 is 3 and Q2 is 3). 
Weak: Outcome assessor is aware of the intervention status of 
participants (Q1 is 1); and study participants are aware of the 
research question (Q2 is 1). 
1 2 3 4 
 
E) DATA COLLECTION METHODS -> STRONG 
(E1 and E2) Were data collection tools shown to be valid and reliable? Yes   
F) WITHDRAWALS, DROP-OUTS AND MISSING DATA 
(F1) Were withdrawals and drop-outs reported in terms of numbers and/or reasons per group?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (for cross-sectional studies) 
(F2) Indicate the percentage of participants completing the study (at the final data collection 
period) (If the percentage differs by groups, record the lowest).  
1 80 -100%  4 Can’t tell 
2 60 - 79%  5 Not applicable (for cross-sectional studies) 
3 less than 60%   
(F3) Was the proportion of missing data similar in the intervention and control groups or 10% or 
less in studies without comparison groups? 
1 Yes           3 Can’t tell  
2 No (-> indicate % missing data:_______________________________) 
 
RATE THIS SECTION  STRONG  MODERATE  WEAK  
Strong: will be assigned when the follow-up rate is >=80% (Q2 is 1) 
or the proportion is similar or missing data <=10% (Q3 is 1). 
Moderate: will be assigned when the follow-up rate is 60 – 79% 
(Q2 is 2) or when missing data is 11-20% (Q3 is 2) or if the 
withdrawals, drop-outs and missing data are not described (Q1 is 
3, Q2 is 4, or Q3 is 3) 
Weak: will be assigned when a follow-up rate is < 60% (Q2 is 3) or 
when missing data is >20% (Q2 is 3). 
1 2 3 
The use of the Patient Assessment of Chronic Illness Care (PACIC) instrument in diabetes care: a systematic review and meta-analysis - p4 
G) INTERVENTION INTEGRITY  
(G1) What percentage of participants received the allocated intervention or exposure of interest?  
1 80 -100%  
2 60 - 79%  
3 less than 60%  
4 Can’t tell  
5 Not applicable (studies without interventions) 
(G2) Was the consistency of the intervention measured?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (studies without interventions) 
 (G3) Is it likely that subjects received an unintended intervention (contamination or co-
intervention) that may influence the results?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (studies without interventions) 
H) ANALYSES  
(H1) Indicate the unit of allocation (circle one) if interventional study 
community  organization/institution  practice/office   individual  not applicable 
(H2) Indicate the unit of analysis (circle one) if interventional study 
community  organization/institution  practice/office   individual  not applicable 
(H3) Are the statistical methods appropriate for the study design?  
1 Yes  
2 No  
3 Can’t tell  
(H4) Is the analysis performed by intervention allocation status (i.e. intention to treat) rather than 
the actual intervention received?  
1 Yes  3 Can’t tell 
2 No  4 Not applicable (studies without interventions) 
 
COMPONENT RATINGS AND GLOBAL RATING 
A. SELECTION BIAS  STRONG  MODERATE  WEAK   
B. STUDY DESIGN  STRONG  MODERATE  WEAK   
C. CONFOUNDERS  STRONG  MODERATE  WEAK  N/A 
D. BLINDING  STRONG  MODERATE  WEAK  N/A 
E. DATA COLLECTION METHODS STRONG MODERATE  WEAK   
F. WITHDRAWALS, DROPOUTS, MISSING DATA  STRONG  MODERATE  WEAK   
Global rating for the paper (circle one): Final decision of both reviewers (circle one): 
 
1 STRONG (no WEAK ratings and 4 or more STRONG ratings)  1 STRONG 
2 MODERATE (one WEAK rating)  2 MODERATE  
3 WEAK (two or more WEAK ratings)  3 WEAK 
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Supplementary table 3. Characteristics of studies using the PACIC instrument among patients with diabetes. 
Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
Chiu & al (2016) 
[1] 
 
 
Study design: Cross-sectional study 
with 2 study groups: pay-for-
performance (P4P) and non-pay-for-
performance (non-P4P) 
Country: Taiwan 
Setting: mixed (medical centers, 
hospitals, clinics) 
HC professionals: physicians 
specialized in diabetology (P4P)  
Type of care:  
P4P: integrated care  
Non-P4P: usual care 
1458 (total) 
P4P: 1037 
Non-P4P: 
421 
Type 2 P4P: 
61.5 (11.4) 
non-P4P: 
61.5 (12.77) 
 
P4P: 49.6% 
Non-P4P: 
46.6% 
Mandarin  
20 items 
Almost never 
to almost 
always 
 
P4P: 4.2 (0.6)  
non-P4P: 3.9 (0.7) 
Dede & al (2016) 
[2] 
Study design: Cross-sectional study 
Country: Turkey 
Setting: hospital clinics (internal 
medicine and pulmonary medicine 
outpatient clinic) 
HC professionals: various specialists 
Type of care: usual care 
76 Type 2 55.0 (12.7) 
 
36.8% Turkish  
20 items 
Never to 
always 
2.9 (0.9) 
Fan & al (2015) 
[3] 
Study design: Cross-sectional study 
Country: USA 
Setting: primary care practice (n=34 
in a practice-based research 
network) 
HC professionals: GPs 
Type of care: usual care  
2055 Type 2 64.9 (12.3) 
 
50.4% English  
20 items 
None of the 
time to all the 
time 
3.0 (1.09) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
Ku & Kegels 
(2015) [4]  
Study design: Before-after study 
(baseline data only) 
Country: Philippines 
Setting: primary care practices 
HC professionals: healthcare workers, 
GPs, nurses, midwives 
Type of care: usual care (at baseline) 
164 Type 2 56.9 (10.8) 25.6% Language ot 
reported  
20 items 
Almost never 
to almost 
always 
3.3 (0.8)  
 
SD calculated from 
95% CI (3.0 – 3.4) 
 
Kuznetsov & al 
(2015) [5] 
 
Study design: cross-sectional 
analyses of cluster-RCT with 2 study 
groups: routine care (RC) and 
intensive multifactoral treatment 
(IMT)  
Country: Denmark 
Setting: primary care practice  
HC professionals: GPs  
Type of care:  
RC: usual care  
IMT: integrated care 
937 (total) 
(6-year 
follow-up 
data) 
RC: 372 
IMT: 565 
Type 2 RC: 65.6 (6.7) 
IMT: 65.5 
(6.9) 
RC: 59.1%  
IMT: 59.1% 
Language not 
reported  
20 items 
Never to 
always 
RC: 2.4 (0.8) 
IMT:2.4 (0.8) 
 
Pintaudi & al 
(2015) [6-8] 
 
Study design: cross-sectional study 
Country: Italy 
Setting: diabetes clinics 
HC professionals: diabetologists, 
nurses, dietitians  
Type of care: usual care 
2374 Type 2 65.0 (10.2) 59.9% Italian  
11 items 
Anchors not 
reported 
0-100 scale 
3.7 (0.8)  
 
Calculated from 
mean PACIC score 
(SD) = 74.4 (16.1) 
Aung & al (2014) 
[9-14] 
  
Study design: cross-sectional 
analyses of prospective cohort (2008 
baseline data only) 
Country: Australia 
3761  Type 2 
 
 
 
62.5 (10.9) 
 
55.3% English  
20 items 
None of the 
time to always 
2.4 (1.6) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
Setting: mixed (population-based) 
HC professionals: mixed (population-
based) 
Type of care: usual care 
Frei & al (2014) 
[15] 
Study design: cross sectional study 
with 2 study groups: non-managed 
care (non-MC) and managed care 
(MC) 
Country: Switzerland 
Setting: primary care practice  
HC professionals: GPs 
Type of care:  
Non-MC: usual care 
MC: integrated care 
374 (total) 
Non-MC: 
326 
MC: 48 
Type 2 Non-MC:  
67.0 (10.6)  
MC: 73.3 
(10.3)  
 
Non-MC:  
57.4% 
MC: 60.4% 
German  
20 items + 6 
(5As) 
Never to 
always 
 
Non-MC: 3.2 (0.9) 
MC: 3.4 (0.7) 
Frei & al (2014) 
[16] 
 
Study design: cluster-RCT (baseline 
data only) 
Country: Switzerland 
Setting: primary care practices 
HC professionals: GPs 
Type of care: usual care (at baseline) 
326 Type 2 67.0 (10.5)  57.7% German  
20 items 
Anchors not 
reported 
3.1 (0.9) 
Glasgow & al 
(2014) [17] 
 
Study design: 2 RCTs (baseline data 
only): ‘My path to healthy life’ trial  
[MyPath] and ‘Reducing Distress and 
Enhancing Effective Management’ 
trial [REDEEM] 
Country: USA 
Setting:  
MyPath: primary care practices 
228 (total) 
MyPath: 
132 
REDEEM: 
96 
Type 2 MyPath: 58.6 
(9.1) 
REDEEM: 55.2 
(10.9) 
 
MyPath: 
48.5% 
REDEEM: 
40.6% 
Language , nb 
of items and 
anchors not 
reported 
(classified as 
20 items) 
MyPath: 3.2 (0.4) 
REDEEM: 2.8 (1.1) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
REDEEM: community (community 
medical groups and diabetes 
education centers) 
HC professionals:  
MyPath: not reported 
REDEEM: not reported 
Type of care:  
MyPath: usual care 
REDEEM: integrated care 
Jiamjarasrangsi 
& al (2014) [18]  
Study design: Cross-sectional study 
with 3 comparison groups: primary 
care unit (PCU) in hospitals [PCU 
hosp], PCU in public health centers 
[PCU comm], and non-PCU in 
hospitals [non-PCU hosp] 
Country: Thailand 
Setting:  
PCU hosp: hospital clinics 
PCU comm: community  
Non-PCU hosp: hospital clinics  
HC professionals: not reported 
Type of care:  
PCU hosp: integrated care 
PCU comm: integrated care 
Non-PCU hosp: usual care 
1000 (total) 
PCU hosp: 
255 
PCU comm: 
659  
Non-PCU 
hosp: 86 
Type 2 PCU hosp: 
60.6 (13.0) 
PCU comm: 
62.2 (10.0) 
Non-PCU 
hosp: 65.0 
(11.6) 
 
PCU hosp: 
29.8% 
PCU comm: 
25.3%  
Non-PCU 
hosp: 44.2% 
Thai  
20 items 
Almost never 
to almost 
always 
PCU hosp: 3.6 (0.7) 
PCU comm: 3.4 
(0.8) 
Non-PCU hosp: 3.1 
(0.4) 
Johnson & al 
(2014) [19-21] 
 
Study design: controlled before-after 
study (baseline data only) 
Country: Canada 
157 Type 2 57.8 (9.8) 44.6% Language and 
anchors not 
reported  
1.7 (1.3) 
 
Calculated from 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
Setting: primary care practice (in 
primary care networks) 
HC professionals: GPs 
Type of care: integrated care 
11 items 
0-100 scale 
mean PACIC score 
(SD) = 34.6 (26.7) 
Ku & al (2014) 
[22] 
 
 
Study design: Cross-sectional study 
with 2 study groups: Veterans 
Memorial Medical Center (VMMC) 
and Local Government Health Units 
(LGHU) 
Country: Philippines  
Setting:  
VMMC: hospital clinics (family 
physician-led tertiary hospital-based 
outpatient clinic)  
LGHU: community centers (local 
government health units) 
HC professionals:  
VVMC: GPs  
LGHU: GPs, nurses, and midwives  
Type of care:  
VVMC: usual care  
LGHU: usual care 
549 (total) 
VMMC: 350 
LGHU: 199 
not 
reported 
VMMC: 65.7 
LGHU: 57.6 
 
VMMC: 50.3% 
LGHU: 25.6% 
Language not 
reported  
20 items 
Almost never 
to almost 
always 
 VVMC: 2.6 (5.2) 
LGHU: 3.2 (0.7) 
 
Unpublished data 
sent by author. SD 
calculated from 
95% CI: VVMC: 2.1-
3.2; LGHU: 3.1-3.3. 
Lewis & al (2014) 
[23] 
Study design: before-after study 
(baseline data only) 
Country: USA 
Setting: mixed (clinical and 
community based care) 
HC professionals: not reported 
257 (with 
PACIC data) 
Type 2 54 (11.6) 
Unpublished 
data sent by 
author. 
26% 
Unpublished 
data sent by 
author. 
English  
20 items 
None of the 
time to always 
3.5 (0.9) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
Type of care: usual care (at baseline) 
Ratanawongsa & 
al (2014) [24, 25] 
 
Study design: step-wedge RCT 
(baseline data only) 
Country: USA 
Setting: clinics in a practice-based 
research network  
HC professionals: GPs 
Type of care: usual care (at baseline) 
252 Type 1 
and 2 
55.8 (8.3)  25.8% English, 
Spanish and 
Cantonese  
20 items 
Anchors not 
reported 
1-100 scale 
2.2 (1.2) 
 
Calculated from 
mean PACIC score 
(SD) = 44.6 (23.4) 
Stock & al (2014) 
[26] 
 
Study design: cross-sectional study in 
2 countries with 2 study groups in 
each country:  Diabetes management 
program (DMP) and routine care 
(non-DMP) in Germany, ProvenCare 
Chronic Diabetes Program (PCDP) 
and routine care (non-PCDP) in USA 
Country: Germany and USA 
Setting:  
Germany: primary care practice 
USA: mixed (PCPs and other 
physicians in a medical group, and 
hospitals)  
HC professionals:  
Germany: GPs 
USA: multispecialty physicians 
Type of care:  
DMP and PCDP: integrated care 
Non-DMP and non-PCDP: usual care 
Germany: 
2470 (total) 
DMP: 1791 
non-DMP: 
679 
USA: 1692 
(total) 
PCDP:  866 
non-PCDP: 
826 
Type 2 DMP: 75.1 
(5.6) 
Non-DMP: 
75.8 (6.0) 
PDCP: not 
reported 
Non-PDCP: 
not reported 
DMP: 50.3% 
Non-DMP: 
53% 
PCDP: 52.7% 
Non-PCDP: 
56.7% 
English and 
German  
20 items 
Anchors not 
reported 
DMP: 2.7 (0.9) 
Non-DMP: 2.4 (0.9) 
PCDP: 2.9 (missing 
SD) 
Non-PCDP: 2.8 
(missing SD) 
 
German data sent 
by authors. 
 
 
Thomas & al Study design: cross-sectional study 89 Type 2 not reported 39.3% Language not 2.9 (1.1) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
(2014) [27] Country: USA 
Setting: primary care practice 
(private physicians network) 
HC professionals: multispecialty 
Type of care: usual care 
reported  
20 items + 6 
(5As) 
Almost never 
to almost 
always 
5A summary score 
 
Tsiachristas & al 
(2014) [28, 29] 
  
Study design: before-after study 
(baseline data only) 
Country: Netherlands 
Setting: primary care practice 
HC professionals: multiple care 
providers (e.g. GP, nurse, dietician, 
physiotherapist) 
Type of care: usual care (at baseline) 
407 
(diabetic 
patients 
only) 
Type 2 66.2 (9.7)  57.0% Dutch  
20 items 
Anchors not 
reported 
3.3 (0.85) 
 
Xue & al (2014) 
[30] 
Study design: cluster-RCT 
Country: USA 
Setting: primary care practices 
HC professionals: not reported 
Type of care: usual care (at baseline) 
221 Type 1 
and 2 
62.9 (10.8) 35.7% English  
20 items 
Anchors not 
reported 
2.4 (1.1)  
 
Unpublished data 
sent by author. 
Zuercher & al 
(2014) [31-33] 
 
 
Study design: cross-sectional 
analyses of prospective cohort 
(baseline data only) 
Country: Switzerland 
Setting: mixed (population-based) 
HC professionals: multiple care 
providers 
Type of care: usual care 
519 Any type 64.5 (11.3)  59.7% French  
20 items 
Never to 
always 
2.8 (0.95) 
Ko & al (2013) Study design: controlled before-after 40 Type 2 58 (13)  60% Language and 3.5 (0.9) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
[34] 
 
study (baseline data only) 
Country: USA 
Setting: community (outpatient care 
services and community outreach 
programs) 
HC professionals: not reported 
Type of care: usual care 
anchors not 
reported  
20 items 
 
Liu & al (2013) 
[35] 
 
Study design: cross-sectional study  
Country: China 
Setting: community health centers 
HC professionals: multiple care 
providers (often exclusively GPs) 
Type of care: integrated care (health 
management) 
960 Type 2 68.3 (10.4) 39.6% Language not 
reported  
20 items 
Almost never 
to almost 
always 
not reported 
 
Author contacted 
but not reply. 
Sansgiry & al 
(2013) [36] 
 
Study design: cross-sectional study 
Country: USA 
Setting: not clear (Veterans Affairs 
center) 
HC professionals: not reported 
Type of care: not reported 
126 not 
reported 
not reported  not reported not reported not reported  
 
Drewes & al 
(2012) [37] 
Study design: cross-sectional study  
Country: Netherlands 
Setting: primary care practice (n=69) 
HC professionals: GPs 
Type of care: integrated care 
1547 Type 2 
(mostly) 
65.7 (11.4) 
 
 
 
53.6% Dutch  
20 items + 6 
items 
regarding 
team 
functioning 
Almost never 
to almost 
2.8 (0.8) 
 
Unpublished data 
sent by author. 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
always 
Ose & al (2012) 
[38, 39] 
 
Study design: cross sectional study 
with 2 study groups: disease 
management program (DMP) and 
routine care (RC)  
Country: Germany 
Setting: primary care practice  
HC professionals: not reported 
Type of care: 
DMP: integrated care 
RC: usual care 
1399 (total) 
DMP: 865 
RC: 534 
Type 2 DMP: 70.2 
(8.3) 
RC: 70.5 (8.9) 
 
  
DMP: 46.2%  
RC: 46.6% 
German  
20 items 
Almost never 
to almost 
always 
DMP: 3.26 (0.9)  
RC: 2.86 (0.9)  
Pemu & al 
(2011) [40] 
 
Study design: before-after study 
(baseline data only) 
Country: USA 
Setting: Primary care practice (in 
community physicians network) 
HC professionals: physicians 
Type of care: usual care (at baseline) 
141 Any type 56 (9.2) 
 
23% Language and 
anchors not 
reported  
20 items 
3.3 (1.1) 
Gugiu & al 
(2010) [41, 42] 
Study design: cross-sectional study  
Country: USA 
Setting: primary care practice 
(physicians and practices network)  
HC professionals: not reported 
Type of care: usual care 
529 Type 2 63.4 (missing 
SD)  
52.7% English  
11 items 
Anchors not 
reported 
0-100 scale 
3.1 (1.9) 
 
Calculated from 
mean PACIC score 
(SD) = 61.7 (38.0), 
estimated from 
Table 2 
Maindal & al 
(2010) [43] 
 
Study design: cross-sectional study 
Country: Denmark 
Setting: mixed  
560 Type 2 66.4 (10.7) 
 
 
60% Danish  
20 items 
Never to 
2.8 (1.4) 
 
Overall score 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
HC professionals: not reported 
Type of care: usual care 
always computed from 
mean and SD of 
each individual 
item 
Wallace & al 
(2010) [44] 
Study design: cross-sectional study 
Country: USA 
Setting: hospital clinic 
HC professionals: multidisciplinary 
team 
Type of care: integrated care  
195 Type 2 58 (missing 
SD) 
36% English  
20 items + 6 
(5As) 
Almost never 
to almost 
always 
3.8 (0.8) 
Schillinger & al 
(2009) [45-47] 
  
Study design: RCT (baseline data 
only) 
Country: USA 
Setting: primary care practice 
HC professionals: GPs 
Type of care: usual care (at baseline) 
339 Type 2 56.1 (missing 
SD) 
41% English, 
Spanish, 
Cantonese 
20 items 
Almost never 
to almost 
always 
 
1-100 scale 
1.95 (1.2)   
 
Calculated from a 
mean PACIC score 
(SD) = 39.0 (24.8) 
 
 
Aragones & al 
(2008) [48] 
Study design: cross-sectional study  
Country: USA 
Setting: hospital clinic 
HC professionals: not reported 
Type of care: integrated care 
100 Type 2 63.7 (10.7) 21% Spanish  
 20 items 
None of the 
time to always 
3.2 (0.8) 
Jackson & al 
(2008) [49] 
 
 
Study design: cross sectional study 
Country: USA 
Setting: primary care practice (in a 
Veteran Affairs medical center) 
189 not 
reported 
65.0 (10.7) 97.9% English  
20 items 
None of the 
time to always 
3.1 (1.1) 
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Author 
(publication 
year) 
Study and healthcare delivery 
characteristics 
Patient characteristics 
 
PACIC instrument and overall score 
on a 5-point scale 
 N Type of 
diabetes 
Age, 
mean(SD)  
Men, %  Language, nb 
of items, 
anchors 
Overall score, 
mean (SD)  
HC professionals: GPs 
Type of care: usual care 
Wensing & al 
(2008) [50] 
 
Study design: cross-sectional study  
Country: Netherlands 
Setting: primary care practice (n=4) 
HC professionals: GPs 
Type of care: integrated care 
88 (diabetic 
patients 
only) 
Type 2 68.8 (8.9) 
 
43% Dutch  
20 items 
Almost never 
to almost 
always 
3.2 (1.0) 
 
Glasgow & al 
(2005) [51] 
 
Study design: cross-sectional study 
Country: USA 
Setting: primary care practice (n=30) 
HC professionals: not reported 
Type of care: usual care 
363 Type 2 64.1 (11.9) 
 
 
52.8% English  
20 items + 6 
(5As) 
Almost never 
to almost 
always 
3.2 (0.9) 
 
RCT: randomized controlled trial, HC: healthcare, GP: general practitioner, SD: standard deviation, nb: number 
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Supplementary table 4. Characteristics of ongoing studies or studies without published results using the PACIC instrument among patients 
with diabetes. 
 
Author (publication year) Study and healthcare delivery characteristics Patient characteristics PACIC instrument 
 N patients 
planned 
Type of 
diabetes 
Language, nb of 
items 
Yu & al (2015) [1] 
 
Study design: Cluster-RCT 
Country: Canada 
Setting: family practice groups (health integration networks) 
HC professionals: physicians, nurses, dietitians and/or 
pharmacists 
Type of care: usual care (at baseline) 
112 (2x56) Type 2 Not reported 
Bozorgmehr & al (2014) 
[2] 
 
 
Study design: RCT 
Country: Germany 
Setting: primary care practice 
HC professionals: GPs 
Type of care: usual care (at baseline)  
582 Type 2 not reported 
11 items 
Drewelow & al (2012) [3] 
 
 
Study design: cluster-RCT 
Country: Germany 
Setting: primary care practice 
HC professionals: GPs 
Type of care: usual care (at baseline) 
780 Type 2 PACIC-D 
Not clear 
Freund & al (2011) [4, 5] Study design: cluster-RCT 
Country: Germany 
Setting: primary care practice (n=130) 
HC professionals: GP or general internist, healthcare assistants 
Type of care: usual care (at baseline) 
2210  Type 2 
 
Not clear 
Versnel & al (2011) [6] 
  
Study design: RCT 
Country: Netherlands 
Setting: primary care practice 
HC professionals: GP, practice nurse, diabetes nurse, dietician 
Type of care: integrated care (at baseline) 
230 Type 2 not reported 
20 items 
 
RCT: randomized controlled trial, GP: general practitioner, HC: healthcare, nb: number 
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